UNSPSC 51372207: Dextromoramide tartrate

This classification denotes an opioid receptor agonist with the molecular formula C25H32N2O2.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J778U505W5, chemically known as pyrrolidine, 1-(3-methyl-4-morpholino-2,2-diphenylbutyryl)-, (+)-, tartrate (1:1) but more generally known as dextromoramide tartrate, which bears US NIH Compound Identifier 92942. European Medicines Agency schedules Dextromoramide tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01647MIG.

UNSPSC 51372207 Dextromoramide tartrate is a Commodity code that shows minimal alignment with actual state and local procurement activity. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems for community health initiatives, not dextromoramide tartrate, a controlled opioid pharmaceutical compound. The mismatch between the code's nominal pharmaceutical scope and the actual procurement signals either a tagging error in the jurisdiction's e-procurement system or a misclassification by the reporting source. Seminole County's solicitation itself is straightforward: the county seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to its Community Health Building in Sanford, Florida, and a two-year initial term plus one-year renewal option. Vendors must include shipping and delivery costs in their proposals, meet drug-free workplace and E-Verify requirements, maintain standard commercial insurance, and comply with potential FEMA-related federal environmental regulations if funding flows through that channel.

The geographic activity appears limited to Florida based on the single identifiable opportunity. The Seminole County procurement closed on July 26, 2023—nearly three years in the past as of October 2026—and no subsequent state or local solicitations under this code are reported in the available data. The absence of recent opportunities, combined with the poor fit between the code definition and the one opportunity on record, suggests this Commodity code sees negligible procurement activity at the state and local level or receives sporadic misclassification when jurisdictions do post health-related purchases. Business development professionals should treat this code as inactive for planning purposes unless direct outreach to state health departments or county public-health procurement offices surfaces current demand for dextromoramide tartrate products specifically.